Psychiatry and Neurology, Neurology · Bronx, NY
NPI
1124103817
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Medical Arts Pavilion, 3400 Bainbridge Avenue, #5a
Bronx, NY, 10467
Phone (718) 920-4730
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
299 services
Medicare patients, 2024
146
Average age 74
Drug cost, 2024
$867K
1,250 prescriptions
Company payments, 2025
$250
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Kaufman was code 99215 (office e&m - established), 147 times for 78 patients. In total David M Kaufman billed 299 services in 17 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 147 | 78 | $125.82 | $18K |
| 99214 Office E&M - Established | Facility | 29 | 26 | $86.88 | $2,520 |
| 99205 Office E&M - New | Facility | 26 | 26 | $150.62 | $3,916 |
By year: 2022 $39K for 325 services; 2023 $39K for 336 services; 2024 $33K for 299 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Kaufman prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 167 prescriptions and refills. In total David M Kaufman wrote 1,250 Medicare prescriptions that cost $867K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 167 | 385 | 47 | $4,733 |
| Gabapentin Generic | 97 | 199 | 34 | $1,848 |
| Primidone Generic | 67 | 148 | 27 | $1,709 |
| Amantadine Amantadine Hcl | 63 | 133 | 23 | $2,612 |
| Ropinirole Hcl Generic | 55 | 101 | 16 | $965 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 42 | 114 | 12 | $2,300 |
| Clonazepam Generic | 41 | 41 | 11 | $613 |
| Donepezil Hcl Generic | 41 | 91 | 17 | $566 |
| Propranolol Hcl Generic | 34 | 50 | 11 | $353 |
| Tetrabenazine Generic | 32 | 42 | Under 11 | $254K |
| Trazodone Hcl Generic | 30 | 50 | Under 11 | $289 |
| Selegiline Hcl Generic | 29 | 61 | Under 11 | $2,467 |
| Levetiracetam Generic | 28 | 54 | Under 11 | $870 |
| Pregabalin Generic | 26 | 30 | Under 11 | $997 |
| Ingrezza Valbenazine Tosylate | 22 | 32 | Under 11 | $262K |
Brand drugs: 75 claims; generic drugs: 1,175 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Kaufman $250 ($250 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbott Laboratories with $149.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.